Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know

Ligand Pharmaceuticals (LGND) closed the last trading session at $79.92, gaining 10.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 116.33 indicates a 45.6% upside potential. The mean estimate comprises three short-term price targets with a standard deviation of $25.11. While the lowest estimate of$ 95 indicates an 18.9% increase from the current price level, the most optimisti ...